Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/2003
09/18/2003US20030175374 Oxidation resistance; anticancer agents, antiinflammatory agents; sunscreen agents
09/18/2003US20030175370 Dry mixture of carbohydrates and drugs; wound healing agents
09/18/2003US20030175334 Phospholipid bodies and use thereof in medical treatment
09/18/2003US20030175313 Preparation of sterile stabilized nanodispersions
09/18/2003US20030175311 A protein encoded by DNA sequence, for protecting poultry; veterinary medicine
09/18/2003US20030175309 Adjuvants for use in vaccines
09/18/2003US20030175308 Adjuvants for use in vaccines
09/18/2003US20030175299 Comprising lecithin, oils, amphiphilic surfactant and an antigen; for protecting pig against a Bordetella infections and/or a toxigenic Pasteuralla infections; stable oil-in-water emulsions, side effect reduction
09/18/2003US20030175298 Comprising lecithin, oils, amphiphilic surfactant and an antigen; for protecting pig against a Bordetella infections and/or a toxigenic Pasteuralla infections
09/18/2003US20030175297 Cancer vaccines
09/18/2003US20030175290 Molecular antigen array
09/18/2003US20030175288 Polypeptides used for induction of cytotoxic T lymphocytes or activation of human leukocyte antigens (HLA), administered as anticarcinogenic vaccines; immunology
09/18/2003US20030175281 Monoclonal antibodies that preferntially bind to proteins having cytolysis and immunogenic activity
09/18/2003US20030175280 Antagonists to chaperonin 10
09/18/2003US20030175274 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents
09/18/2003US20030175269 Light and heavy chain peptides, used as antagonists of CD antigen or membrane proteins, for prophylaxis of autoimmune diseases
09/18/2003US20030175258 Mixing shoots of Pinaceae plants with water and saccharides followed by spontaneous fermenting with yeasts to form remedies for allergic diseases; side effect reduction; for treatment of asthma, atopic dermatitis
09/18/2003US20030175249 For labeling/activating antigen presenting cells; chaperone proteins
09/18/2003US20030175247 For activating lymphocytes (CD-8 antigens) in response to metastatic cancer; tumor associated antigens; major histocompatibility complex; cryopreservation; prostate specific antigen
09/18/2003US20030175238 Chemokine conjugates
09/18/2003US20030175205 Comprising a radioactive materials for detecting and/or quantifying diseases or conditions associated with cancer, infections, inflammation; a 2-propane carboxylic ester with a attached phosphatidic acid group
09/18/2003DE20121877U1 Module for suppressing leukocyte activity, useful e.g. in association with heart-lung machines, comprises a carrier linked to a ligand specific for the leukocyte receptor
09/18/2003CA2813780A1 Genetic products differentially expressed in tumors and use thereof
09/18/2003CA2478942A1 An optically active pyridine derivative and a medicament containing the same
09/18/2003CA2478921A1 Novel chalcone derivatives and uses thereof
09/18/2003CA2478897A1 Compounds capable of inhibiting immunocyte-related allergic immune reactions
09/18/2003CA2478701A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/18/2003CA2478684A1 Dispersed solid-containing complex carbohydrate
09/18/2003CA2478652A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003CA2478317A1 Methods of preventing or treating disorders by administering an integrin .alpha.v.beta.3 antagonist in combination with an hmg-coa reductase inhibitor or a bisphosphonate
09/18/2003CA2478245A1 Treatment and prevention of inflammatory disorders
09/18/2003CA2478065A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003CA2477780A1 Methods of enhancing immune induction involving mda-7
09/18/2003CA2477675A1 Immunizing composition and method for inducing an immune response against the .beta.-secretase cleavage site of amyloid precursor protein
09/18/2003CA2476031A1 Novel substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
09/18/2003CA2474771A1 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
09/17/2003EP1344826A1 Materials comprising and methods of preparation and use for ribosome - inactivating proteins
09/17/2003EP1344823A1 Novel g protein-coupled receptor proteins and dnas thereof
09/17/2003EP1344779A1 Azolo-pyrimidines
09/17/2003EP1344525A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
09/17/2003EP1344458A1 Probiotic delivery system
09/17/2003EP1344063A1 A screening assay for antagonists of human leukocyte receptors
09/17/2003EP1343912A2 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
09/17/2003EP1343900A2 Oxidoreductases
09/17/2003EP1343888A2 Regulation of human chemokine-like receptor
09/17/2003EP1343886A2 Compositions and methods for the therapy and diagnosis of lung cancer
09/17/2003EP1343876A2 Modulators of activity of g-protein-coupled receptor kinases
09/17/2003EP1343826A1 Polysaccharide compound having immune stimulating activity
09/17/2003EP1343814A2 Immunogenic glycopeptides, screening, preparation and uses
09/17/2003EP1343813A1 Novel compounds
09/17/2003EP1343786A1 Novel pyridine-substituted pyrazolopyridine derivatives
09/17/2003EP1343784A2 Urea substituted imidazoquinoline ethers
09/17/2003EP1343781A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
09/17/2003EP1343769A1 Benzoylpyridazines
09/17/2003EP1343759A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands
09/17/2003EP1343757A1 Indole derivatives
09/17/2003EP1343751A2 Cyclic derivatives as modulators of chemokine receptor activity
09/17/2003EP1343561A1 Serine protease inhibitors
09/17/2003EP1343527A2 Adjuvant combination formulations
09/17/2003EP1343525A2 IMPROVED i MYCOPLASMA HYOPNEUMONIAE /i BACTERIN VACCINE
09/17/2003EP1343520A2 New therapeutic uses of smr1 peptides
09/17/2003EP1343513A1 Compositions containing an active fraction isolated from scutellariae barbatae and methods of use
09/17/2003EP1343512A1 Injectable solution with anti-inflammatory effect and process for manufacturing the same
09/17/2003EP1343506A1 Pharmaceutical formulation containing pyrazolo 4,3-d]pyrimidines and antithrombotic agents, calcium-antagonists, prostaglandins or prostaglandin derivatives
09/17/2003EP1343505A1 Cxcr3 antagonists
09/17/2003EP1343487A2 Methods and compositions to treat conditions associated with neovascularization
09/17/2003EP1343486A1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration
09/17/2003EP1343370A2 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
09/17/2003EP1282622B1 Crf receptor antagonists and methods relating thereto
09/17/2003EP1192163B1 DITHIEPINO 6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS
09/17/2003EP1183241B1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
09/17/2003EP1169056B1 Caspase-8 inhibitors for immunosuppression.
09/17/2003EP1147119B1 2,3-o-isoproylidene derivatives of monosaccharides as cell adhesion inhibitors
09/17/2003EP1133471B1 Hydrazine derivatives
09/17/2003EP1123296B1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
09/17/2003EP1082131B1 Immunoregulator
09/17/2003EP1027359B9 Monocyclic l-nucleosides, analogs and uses thereof
09/17/2003EP1003560B1 Radioprotectant for peptides labeled with radioisotope
09/17/2003EP1001798B1 Method for preventing or treating a human immunodeficiency virus infection
09/17/2003EP0996446B1 Novel substituted imidazole compounds
09/17/2003EP0914114B1 Methods of treating type i hypersensitivity using monophosphoryl lipid a
09/17/2003EP0769940B1 INDENE sPLA2 INHIBITORS
09/17/2003EP0768089B1 Hot water extract of Cordyceps sinensis
09/17/2003EP0588858B1 IMIDAZO 2,1-b] 3]BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD OF USE
09/17/2003EP0571613B1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
09/17/2003CN1443241A Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, proteins encoded, and uses thereof
09/17/2003CN1443199A Antibodies to human MCP-1
09/17/2003CN1443197A Acid-modified arabinogalactan protein composition
09/17/2003CN1443196A Protein complex serving as vehicle for orally administerable medicaments
09/17/2003CN1443187A Fused cyclic compounds as modulators of nuclear hormone receptor function
09/17/2003CN1443184A 嘧啶衍生物 Pyrimidine derivatives
09/17/2003CN1443173A Substituted imidazoles as TAFI a inhibitors
09/17/2003CN1443164A Pyrrolidine derivatives as metalloprotease inhibitors
09/17/2003CN1443163A Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors
09/17/2003CN1443077A CD40-binding APC-activating molecules
09/17/2003CN1443073A Process for preparing composition comprising medicinal herb extract for preventing and curing arthritis and composition thereof
09/17/2003CN1442426A Diterpene compound of veronicastrum sibiricum and its extraction separation method
09/17/2003CN1442425A Adjuvent DC-chol, its liposome, preparation method and its use
09/17/2003CN1442151A Mackefulan immune liquid
09/17/2003CN1442150A Composite immune enhancing agent for abolone fry
1 ... 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 ... 1172